Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult …C0NTINUE READING HERE>>>
Semaglutide has been approved by the Food and Drug Administration (FDA) for type 2 diabetes management, weight loss, and heart disease prevention. About 137 million Americans—more than half of all adults—are eligible for this drug based on these treatment indications, according to a recent JAMA Cardiology research letter.
“The numbers are truly staggering,” said Dhruv S. Kazi, MD, MSc, MS, an associate professor of medicine at Harvard Medical School and senior author of the…
Over 50% of U.S. Adults Are Eligible for Ozempic and Wegovy, But Access Remains Difficult …CLICK HERE TO C0NTINUE READING >>>